- Home
- PRLD vs SYTA Comparison
PRLD vs SYTA Comparison
Compare PRLD & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SYTA
- Stock Information
- Founded
- PRLD 2016
- SYTA N/A
- Country
- PRLD United States
- SYTA Canada
- Employees
- PRLD N/A
- SYTA N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SYTA Telecommunications Equipment
- Sector
- PRLD Health Care
- SYTA Telecommunications
- Exchange
- PRLD Nasdaq
- SYTA Nasdaq
- Market Cap
- PRLD 44.0M
- SYTA 38.2M
- IPO Year
- PRLD 2020
- SYTA 2020
- Fundamental
- Price
- PRLD $1.01
- SYTA $2.79
- Analyst Decision
- PRLD Strong Buy
- SYTA
- Analyst Count
- PRLD 3
- SYTA 0
- Target Price
- PRLD $4.00
- SYTA N/A
- AVG Volume (30 Days)
- PRLD 133.9K
- SYTA 769.8K
- Earning Date
- PRLD 08-14-2025
- SYTA 08-14-2025
- Dividend Yield
- PRLD N/A
- SYTA N/A
- EPS Growth
- PRLD N/A
- SYTA N/A
- EPS
- PRLD N/A
- SYTA N/A
- Revenue
- PRLD $7,000,000.00
- SYTA $11,883,835.00
- Revenue This Year
- PRLD N/A
- SYTA $18.41
- Revenue Next Year
- PRLD N/A
- SYTA N/A
- P/E Ratio
- PRLD N/A
- SYTA N/A
- Revenue Growth
- PRLD N/A
- SYTA 49.13
- 52 Week Low
- PRLD $0.61
- SYTA $0.93
- 52 Week High
- PRLD $5.95
- SYTA $29.20
- Technical
- Relative Strength Index (RSI)
- PRLD 52.78
- SYTA 36.59
- Support Level
- PRLD $0.75
- SYTA $3.23
- Resistance Level
- PRLD $0.96
- SYTA $3.85
- Average True Range (ATR)
- PRLD 0.08
- SYTA 0.31
- MACD
- PRLD 0.01
- SYTA -0.11
- Stochastic Oscillator
- PRLD 67.87
- SYTA 0.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.